POTASSIUM CARBONATE

N/A

Manufactured by Boiron

197 FDA adverse event reports analyzed

Last updated: 2026-04-15

About POTASSIUM CARBONATE

POTASSIUM CARBONATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Boiron. The most commonly reported adverse reactions for POTASSIUM CARBONATE include ACUTE KIDNEY INJURY, HYPOPHAGIA, DIARRHOEA, FATIGUE, HEADACHE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for POTASSIUM CARBONATE.

Top Adverse Reactions

ACUTE KIDNEY INJURY9 reports
HYPOPHAGIA8 reports
DIARRHOEA5 reports
FATIGUE5 reports
HEADACHE5 reports
PNEUMONIA5 reports
COUGH4 reports
DECREASED APPETITE4 reports
DIZZINESS4 reports
DYSPNOEA4 reports
NAUSEA4 reports
PYREXIA4 reports
BACK PAIN3 reports
CONSTIPATION3 reports
DYSPEPSIA3 reports
FALL3 reports
GAIT DISTURBANCE3 reports
PAIN3 reports
PRURITUS3 reports
VOMITING3 reports
ABDOMINAL PAIN2 reports
ARTHRALGIA2 reports
ASTHENIA2 reports
ATRIAL SEPTAL DEFECT2 reports
BLOOD CREATININE INCREASED2 reports
CHEST DISCOMFORT2 reports
CHEST PAIN2 reports
CHILLS2 reports
CHRONIC KIDNEY DISEASE2 reports
DRUG INEFFECTIVE2 reports
DRUG INTERACTION2 reports
DYSPHAGIA2 reports
GENERAL PHYSICAL HEALTH DETERIORATION2 reports
HYPERSENSITIVITY2 reports
HYPERTENSION2 reports
HYPOAESTHESIA2 reports
INJECTION SITE SWELLING2 reports
LEUKOPENIA2 reports
LIPASE INCREASED2 reports
MALIGNANT NEOPLASM PROGRESSION2 reports
MUSCULOSKELETAL STIFFNESS2 reports
MYALGIA2 reports
NECK PAIN2 reports
OFF LABEL USE2 reports
OVARIAN CYST2 reports
PELVIC PAIN2 reports
RASH2 reports
ROTATOR CUFF SYNDROME2 reports
SINUSITIS2 reports
VENTRICULAR SEPTAL DEFECT2 reports
WEIGHT DECREASED2 reports
WEIGHT INCREASED2 reports
ABDOMINAL DISCOMFORT1 reports
ABDOMINAL DISTENSION1 reports
ABDOMINAL PAIN LOWER1 reports
ABDOMINAL PAIN UPPER1 reports
ACTINIC KERATOSIS1 reports
ALOPECIA1 reports
ALTERED STATE OF CONSCIOUSNESS1 reports
ANAEMIA1 reports
ANAPHYLACTIC REACTION1 reports
ANKLE OPERATION1 reports
APPETITE DISORDER1 reports
AREFLEXIA1 reports
ARTHROPATHY1 reports
ATRIAL FIBRILLATION1 reports
AUTOIMMUNE INNER EAR DISEASE1 reports
AXILLARY PAIN1 reports
BLISTER1 reports
BLOOD BILIRUBIN INCREASED1 reports
BLOOD FOLATE INCREASED1 reports
BLOOD GLUCOSE ABNORMAL1 reports
BLOOD LACTATE DEHYDROGENASE INCREASED1 reports
BLOOD PHOSPHORUS DECREASED1 reports
BOWEN^S DISEASE1 reports
BREAST CYST1 reports
BREAST PAIN1 reports
BURSITIS1 reports
CALCULUS URETERIC1 reports
CENTRAL NERVOUS SYSTEM LESION1 reports
CEREBROVASCULAR ACCIDENT1 reports
CERVICOBRACHIAL SYNDROME1 reports
CHANGE OF BOWEL HABIT1 reports
CHOLANGITIS1 reports
CHOLECYSTITIS ACUTE1 reports
CHOLELITHIASIS1 reports
CIRCULATORY COLLAPSE1 reports
COLON CANCER STAGE IV1 reports
COMPRESSION FRACTURE1 reports
CONTUSION1 reports
CYST1 reports
CYSTITIS1 reports
CYTOKINE RELEASE SYNDROME1 reports
DEAFNESS1 reports
DEATH1 reports
DEHYDRATION1 reports
DERMATITIS ALLERGIC1 reports
DIABETES MELLITUS1 reports
DIVERTICULUM1 reports
DRUG EFFECT DECREASED1 reports

Report Outcomes

Out of 56 classified reports for POTASSIUM CARBONATE:

Serious 89.3%Non-Serious 10.7%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female24 (51.1%)
Male23 (48.9%)

Reports by Age

Age 789 reports
Age 604 reports
Age 573 reports
Age 582 reports
Age 652 reports
Age 712 reports
Age 561 reports
Age 591 reports
Age 641 reports
Age 661 reports
Age 671 reports
Age 691 reports
Age 731 reports
Age 771 reports
Age 791 reports
Age 821 reports
Age 831 reports
Age 871 reports
Age 196251 reports
Age 305701 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with POTASSIUM CARBONATE?

This profile reflects 197 FDA FAERS reports that mention POTASSIUM CARBONATE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for POTASSIUM CARBONATE?

Frequently reported terms in FAERS include ACUTE KIDNEY INJURY, HYPOPHAGIA, DIARRHOEA, FATIGUE, HEADACHE, PNEUMONIA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures POTASSIUM CARBONATE?

Labeling and FAERS entries often list Boiron in connection with POTASSIUM CARBONATE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.